# Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the communicable diseases and related special health issues to be covered by epidemiological surveillance as well as relevant case definitions (Text with EEA relevance), Division: BJ-DISC: Disc space infection

Extent: E+W+S+N.I.

Vertebral disc space infection must meet at least one of the following criteria:
Patient has organisms cultured from vertebral disc space tissue obtained during a surgical operation or needle aspiration
Patient has evidence of vertebral disc space infection seen during a surgical operation or histopathologic examination
Patient has fever (> 38 °C) with no other recognized cause or pain at the involved vertebral disc space
AND radiographic evidence of infection (for example, abnormal findings on X-ray, CT scan, MRI, radiolabel scan (gallium, technetium, etc.)).
Patient has fever (> 38 °C) with no other recognized cause and pain at the involved vertebral disc space
AND positive antigen test on blood or urine (for example, Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, or Group B Streptococcus).

---
Source: https://www.legislation.gov.uk/eudn/2018/945/annex/II/division/4/division/4.1/division/4.1.1/division/3 (the official version)
Page: https://openlegislation.uk/eu-decision-2018-945/annex-II/division-4/division-4.1/division-4.1.1/division-3
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.